One proposed hypothesis for the loss of BRCA1 methylation following chemotherapeutic treatment and the emergence of resistant tumor recurrences is the rapid expansion of a non-methylated subclone from a heterogeneous tumor cell population that contains BRCA1meth and nonBRCA clones. Here, BRCA1 is linked to neoplasm.